SCHEMBL9937683

SCHEMBL9937683

COc1ccccc1-c1cc(C(=O)NC(Cc2ccc(-c3ccccc3)cc2)C[C@@H](O)C(=O)O)[nH]n1

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MME P08473 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9930080 1.00 MME (0.75) MME
SCHEMBL9930157 0.92 MME (0.75) MME
SCHEMBL9937612 0.92 MME (0.75) MME
SCHEMBL9938743 0.91 MME (0.70) MME
SCHEMBL9930505 0.91 MME (0.70) MME
SCHEMBL9929438 0.86 MME (1.00) MME
SCHEMBL9929436 0.86 MME (1.00) MME
SCHEMBL9929773 0.86 MME (1.00) MME
SCHEMBL9929566 0.85 MME (1.00) MME
SCHEMBL9929567 0.85 MME (1.00) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651896-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-10-23 EP disclosed
WO-2012082853-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-06-21 WO disclosed